<DOC>
	<DOCNO>NCT00586599</DOCNO>
	<brief_summary>The goal study assess relative level Stat4 alpha Stat4 beta isoforms PBMCs patient Crohn 's Disease , ulcerative colitis , celiac disease control patient . We hypothesize beta alpha ratio high patient active disease correlation ratio severity disease .</brief_summary>
	<brief_title>Levels Stat4 Alpha Stat4 Beta Isoforms PBMCs From Patients With Crohn 's Disease Ulcerative Colitis</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Colitis , Ulcerative</mesh_term>
	<mesh_term>Crohn Disease</mesh_term>
	<mesh_term>Colitis</mesh_term>
	<mesh_term>Inflammatory Bowel Diseases</mesh_term>
	<criteria>Children new diagnosis Crohn 's Disease whose physician yet initiate corticosteroid treatment ( 10 Subjects ) : Clinical diagnosis within previous 21 day Above age 7 young age 18 Signed inform consent statement assent statement . Children new diagnosis Ulcerative Colitis whose physician yet initiate corticosteroid treatment ( 10 Subjects ) : Clinical diagnosis within previous 21 day Above age 7 young age 18 Signed inform consent statement assent statement . Children Crohn 's Disease whose physician initiate Infliximab treatment first time ( 10 Subjects ) : Clinical diagnosis Crohn 's Disease Above age 7 young age 18 Signed inform consent statement assent statement . Children Ulcerative Colitis whose physician initiate Infliximab treatment first time ( 10 Subjects ) : Clinical diagnosis Ulcerative Colitis Above age 7 young age 18 Signed inform consent statement assent statement . Healthy Controls ( 10 Subjects ) : Above age 7 young age 18 otherwise healthy , intercurrent illness determine member study team use eligibility checklist control gender age ( Â± 2 year ) match patient group describe Signed inform consent statement assent statement unwilling give consent study . child prior prescription administration Infliximab</criteria>
	<gender>All</gender>
	<minimum_age>7 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>IBD</keyword>
	<keyword>CD</keyword>
	<keyword>UC</keyword>
	<keyword>Crohn 's Disease</keyword>
	<keyword>Ulcerative Colitis</keyword>
	<keyword>Pediatric</keyword>
	<keyword>inflammatory marker</keyword>
</DOC>